NovaBay rebrands to SDEV, buys and stakes SKY tokens in NYSE listing pivot
NYSE-listed NovaBay Pharmaceuticals filed an 8-K to pivot fully into crypto. The company will rebrand as **Stablecoin Development Corporation** and start trading on **NYSE American** under ticker **SDEV** from 3 April.
NovaBay disclosed it holds about **2.06 billion SKY** tokens (as of 16 March) and has accumulated staking rewards. It described **SKY-related on-chain activities**, signaling a shift toward an on-chain treasury model built around **SKY** custody, staking and network participation. The filing does not fully explain how the **SKY** position was accumulated.
For traders, the key market impact is demand for **SKY** tied to recurring yield rather than pure price appreciation. The earlier accounting of a large governance-token purchase and the later disclosure of staking flows/intent reinforce the same theme: **SKY** governance influence can increase as the company moves into staking and potential voting participation. Watch for follow-on **SKY** buy/stake updates, how SDEV votes on roadmap items, and any SEC/accounting guidance that could affect corporate token exposure.
Bullish
This event is positive for **SKY** because SDEV (formerly NovaBay) disclosed a very large token holding (around 2.06B SKY) and a clear intention to stake **SKY**. Staking-related participation can translate into sustained underlying demand (tokens locked to earn yield) and can increase narrative strength around governance influence, which often supports price on both news and subsequent flow updates. Short-term, the rebrand and disclosure can keep upside pressure if markets expect more **SKY** buy/stake follow-through. Longer-term, the impact depends on how SDEV’s disclosures and SEC/accounting guidance shape market confidence in corporate token exposure, but the stated shift toward recurring yield makes the overall bias for **SKY** demand moderately constructive rather than purely speculative.